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1. Introduction  
The pluripotent nature of embryonic stem cells (ESCs) makes them amenable for 
regenerative therapies because they can differentiate into cells that form all tissue types 
within the body (Zandstra and Nagy, 2001). The potential drawbacks to the use of ESCs for 
cellular therapies include the obvious ethical dilemmas of obtaining ESCs, the potential of 
cancer or tumor formation and the risk of immunogenic rejection (Wobus and Boheler, 
2005). Therefore adult stem cell sources with multipotent and pluripotent potential have 
been sought as an alternative for ESCs including mesenchymal stem cell (MSCs) and tissue-
derived specific stem cells. 
Interestingly, the isolation of a population of dental stem cells derived ectodermally from 
the neural crest (NC) have been shown to be multipotent and give rise to multifarious cell 
types that result in the development of many of the body’s organs or tissues (Huang et al., 
2009a; Huang et al., 2009b). Stem cells extracted from dental tissues including dental pulp, 
periodontal ligament, apical papilla and dental follicle precursor cells have an expansive 
differentiation potential with respect to mesodermal and ectodermal lineages.  Currently 
there are six types of dental stem cells that are well characterized and described both in vitro 
and in vivo (Gronthos et al., 2000; Huang et al., 2009a; Karaöz et al., 2010; Miura et al., 2003; 
Morsczeck et al., 2005; Seo et al., 2004; Sonoyama et al., 2006). 
Some dental stem cells lines have been shown to express ESC markers Oct4, Nanog, Sox2 
and Klf4 and NC markers p75, Sox10, Slug and Nestin suggesting that dental stem cells may 
be able to become many of the same tissues as ESCs (Huang et al., 2009a). Further, dental 
stem cells have been shown to differentiate into neurogenic, adipogenic, cardiomyogenic, 
chondrogenic, myogenic and osteogenic lineages (Huang et al., 2009a; Karaöz et al., 2010; 
Miura et al., 2003; Seo et al., 2004; Sonoyama et al., 2006; Zhang et al., 2006). Since dental 
stem cells have been shown to differentiate into a multitude of cell types, their potential for 
use in tissue regeneration may be boundless.  
We are currently using dental stem cells to investigate the mechanisms of 
mechanotransduction elicited during dynamic cyclic compression for chondrogenesis. Our 
long term goal is to develop technology and protocols utilizing dental stem cells and 
biomechanical force for reparative medicine and tissue regeneration of cartilage. This review 
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will discuss the most current findings in tissue engineering with respect to dental stem cells 
both for whole tooth regeneration and potential use in future stem cell therapies. 
2. Characteristics and sources of stem cells 
2.1 What is a stem cell?  
The general properties that define a stem cells are:  1. Stem cells are cells that are clonogenic 
and have the ability for self-renewal; 2. Stem cells are unspecialized cells that when correctly 
stimulated have the ability to differentiate into specialized cell types (Blau et al., 2001; 
Bongso and Fong, 2009). 
There are two broader categories of stem cells: embryonic stem cells (ESCs) and adult stem 
cells. Embryonic stem cells are derived from the blastocyst stage of a developing embryo 
(Fortier, 2005; Thomson et al., 1998) and are capable of forming all three germ layers 
(ectoderm, endoderm, and mesoderm)(Bongso and Fong, 2009). Harvesting ESCs requires 
the destruction of the embryo (Lanzendorf et al., 2001) which leads to ethical dilemmas 
when obtaining these cells. The use of adult stem cells avoids these ethical issues. Adult 
stem cells have been obtained from multiple tissues including bone marrow (Pittenger et al., 
1999), adipose tissue (Zuk et al., 2001), muscle (Deasy et al., 2001), umbilical cord tissue 
(Schugar et al., 2009), intestine (Wong, 2004), and skin (Blanpain et al., 2004). While most of 
this book focuses on the embryonically derived stem cells, this chapter focuses on the adult 
or postnatal stem cells with special emphasis on those derived from dental tissues.  
2.2 Stem cell potency  
Stem cell potency refers to the ability of the cell to differentiate into specific tissue type(s). 
Totipotent is defined as the ability to differentiate into any of the cell types of the entire 
organism, both embryonic and adult cell types (Dannan, 2009; Mummery et al., 2011; Smith, 
2006). An example of a totipotent cell is a fertilized egg cell because it is able to differentiate 
into embryonic, extra-embryonic (ie. placenta) and adult tissues of the entire organism 
(Alison et al., 2002; Dannan, 2009; Mummery et al., 2011).  Pluripotent stem cells have the 
potential to differentiate into all cell lineages including the three germ layers: ectoderm, 
mesoderm, or endoderm but not the extra-embryonic tissues (Alison et al., 2002; Dannan, 
2009; Fortier, 2005; Mummery et al., 2011; Smith, 2006). ESCs are considered the gold 
standard of stem cells because of their pluripotency and their ability to be maintained 
indefinitely in culture (Thomson et al., 1998). Pluripotency has also been demonstrated in 
adult stem cells including bone marrow mesenchymal stem cells (BMMSCs) (Jiang et al., 
2002). Multipotent stem cells have the ability to differentiate into multiple cell lineages that 
can form more than one tissue type (Alison et al., 2002; Mummery et al., 2011; Smith, 2006). 
Mesenchymal stem cells (MSCs) derived from adipose tissue are an example of a 
multipotent stem cell and are able to differentiate into multiple tissues of the mesodermal 
lineage including bone, fat and cartilage (Zuk et al., 2002). 
2.3 Bone marrow mesenchymal stem cells  
Stem cells obtained from bone marrow are a major source of adult MSCs and are widely 
studied. Bone marrow stromal cells can be harvested from bone marrow by mechanical 
disruption, but the cell suspension will contain both hematopoietic stem cells and BMMSCs 
(Bianco et al., 2001). BMMSCs are isolated as colony forming unit-fibroblasts (CFU-Fs) from 
the bone marrow cell suspension. In order to separate the two types of stem cells, the cell 
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suspension is cultured in vitro at low density. A small number of BMMSCs will adhere to 
the plate and begin to form colonies while the non-adherent hematopoietic cells are then 
removed by repeat washings (Bianco et al., 2001; Chamberlain et al., 2007). BMMSCs 
isolated in this manner are capable of 20–25 passages in vitro without significant changes to 
the cell phenotype (Bianco et al., 2001; Conget and Minguell, 1999). Gronthos et al. (2003) 
further showed that BMMSCs could be isolated from bone marrow aspirates by determining 
which CFU-F colonies were highly reactive to the antibody STRO-1 (STRO-1Bright) and also 
reactive to the antibody VCAM-1 (VCAM-1+). These new studies isolated BMMSCs in bone 
marrow aspirates based on STRO-1Bright/ VCAM-1+ cell surface markers by florescence 
activated cell sorting (FACS) and were capable of proliferating up to 40 population 
doublings (Gronthos et al., 2003).   
BMMSCs show a great level of plasticity and have shown the potential to differentiate into 
multiple tissue types in vitro including muscle, adipose, cartilage, bone, connective tissue, 
neurons and endothelial cells (Gronthos et al., 2003; Pittenger et al., 1999; Woodbury et al., 
2000; Young and Black, 2004). Interestingly, when transplanted into immunodeficient mice, 
BMMSCs undergo osteogenic differentiation in vivo and form bone (Kuznetsov et al., 1997).  
In 2006, the minimum criteria to define human multipotent mesenchymal stromal cells was 
established as: Cells that are plastic adherent in standard culture; Cells that have the ability 
to differentiate in vitro into osteoblasts, adipocytes and chondroblasts;  Cells that express 
the cell surface markers CD73, CD90 and CD105 in 95% of the cell population as determined 
by flow cytometry and lack the expression ( ≤ 2% positive) of CD14, CD34, CD45 or CD11b, 
CD79a or CD19 and HLA class II (Dominici et al., 2006).  
2.4 Dental stem cells 
Dental stem cells are an alternative source of adult stem cells that are easily accessible by 
tooth extraction with a local anesthetic or when a primary tooth is replaced. This section 
discusses where dental stem cells arise during tooth formation and the types of tissue they 
form. We also characterize the many types of the dental stem cells utilized in research today 
and compare the utility of dental stem cells versus BMMSCs.  
There are six types of human dental stem cells that have been well described in the 
literature: 1. Dental pulp stem cells (DPSCs) (Gronthos et al., 2000); 2. Stem cells isolated 
from human exfoliated deciduous teeth (SHEDs) (Miura et al., 2003); 3. Stem cells derived 
from human natal dental pulp (hNDPs) (Karaöz et al., 2010); 4. Periodontal ligament stem 
cells (PDLSCs) (Seo et al., 2004); 5. Stem cells isolated from the apical papilla (SCAPs) 
(Sonoyama et al., 2008); 6. Stem cells isolated from dental follicle precursor cells (DFPCs) 
(Morsczeck et al., 2005). 
Within the body, MSCs have been localized to perivascular niches (Crisan et al., 2009; Kolf et 
al., 2007) and recent studies have also shown that dental stem cells are also localized to 
perivascular niches within the tooth structure (Chen et al., 2006; Shi and Gronthos, 2003). 
Dental stem cells arise from dental mesenchyme which has early interaction with the neural 
crest during normal tooth development (Huang et al., 2009b). Therefore, dental stem cells 
may display characteristics of both mesoderm and ectoderm due to their ectomesenchymal 
origins (Huang et al., 2009b). 
2.4.1 Mammalian tooth formation  
A mature tooth is comprised externally of hard structures of enamel, dentin and cementum 
and internally possesses a soft dental pulp (Figure 1). Tooth formation or odontogenesis is a 
www.intechopen.com
 
Embryonic Stem Cells – Differentiation and Pluripotent Alternatives 454 
complex process involving multiple tooth-associated cell types. Odontogenesis occurs as a 
tooth bud is formed from an aggregation of embryonic cells. These cells have ectodermal 
and ectomesodermal origins from the first branchial arch and the neural crest respectively 
(Ten Cate, 1998; Tucker and Sharpe, 2004). Tooth development has three stages. 1. The bud 
stage, where epithelial cells begin to proliferate into ectomesenchyme and condense in the 
jaw forming the tooth bud. 2. The cap stage, where ectomesenchmyal cells aggregate and 
begin to surround and enclose the epithelial cells which invaginate further into the 
mesenchyme and form the dental follicle, the enamel organ or cap and the dental papilla 
(Slatter, 2002; Ten Cate, 1998; Tucker and Sharpe, 2004). The dental follicle is of 
ectomesodermal origins and forms a sac surrounding the developing tooth that supports the 
tooth prior to eruption. The enamel organ is of ectodermal origins and eventually forms the 
enamel, whereas the dental papilla is of mesodermal origins and eventually forms the 
primary dentin and the pulp. 3. The bell stage, where the tooth undergoes extensive 
differentiation with the epithelial cells differentiating into ameloblasts and mesenchymal 
cells differentiating into odontoblasts. After the bell stage, the hard structures are formed 
with ameloblasts forming enamel while odontoblasts form dentin (Figure 1). Secondary 
dentin aids in root formation. Later in tooth development further differentiation of the 
dental follicle occurs with the formation of cementoblasts, fibroblasts and osteoblasts to 
form the cementum, the periodontal ligament and bone respectively (Figure 1).  
2.4.2 Sources of dental stem cells 
2.4.2.1 Dental Pulp Tissue  
The soft dental pulp is located in the middle of the tooth surrounded by the harder 
structures of the tooth including dentin, cementum and enamel (Figure 1). The dental pulp 
contains a mix of cell types including fibroblasts which form the extracellular matrix and 
collagen and odontoblasts that form reparative dentin (Gronthos et al., 2002; Liu et al., 2006). 
The dental pulp region also contains nerve fibers and blood vessels and is accessible to 
external stimuli through the apical foramen (Figure1). Three types of stem cells have been 
identified from dental pulp tissue: DPSCs, SHEDs and hNDPs. DPSCs are present in the 
pulp of the adult tooth, whereas SHEDs are only present in the pulp of primary teeth or 
“baby teeth.”  Lastly, hNDPs are a unique type of dental pulp stem cells isolated only from 
the pulp of newborn teeth. Very few newborns are born with teeth, approximately one in 
every two to three thousand births (Leung and Robson, 2006), so hNDPs are very rare. 
2.4.2.1.1 Dental Pulp Stem Cells  
DPSCs are a heterogeneous population of cells that were first isolated by Gronthos et al. 
(2000) and exhibited some characteristics of BMMSCs, including the production of 
fibroblast-like cells that were clonogenic and had a high proliferation rate. Interestingly,  
DPSCs had a higher proliferation rate than BMMSCs (Gronthos et al., 2000) . DPSCs also 
had a similar protein expression pattern to BMMSCs in vitro including vascular adhesion 
molecule 1, alkaline phosphatase, collagen I, collagen III, osteonectin, osteopontin, 
osteocalcin, bone sialoprotein, ǂ-smooth muscle actin, fibroblast growth factor 2 and the cell 
surface marker CD 146 (Gronthos et al., 2000). Immunohistochemistry staining further 
showed that like BMMSCs, primary cultures of DPSCs did not stain for the cell surface 
markers CD14, CD34, and CD45 or other markers including MyoD, neurofilament, collagen 
II , and peroxisome-proliferator activated receptor Ǆ-2 (Gronthos et al., 2000). 
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Fig. 1. Mature tooth anatomy. Image copied with permission from Dr. Martin S. Spiller, 
D.M.D. from DoctorSpiller.com. 
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Recently FACS has been used to sort DPSCs based on cell surface markers which found that 
in addition to the markers identified above, DPSCs expressed the following: CD9, CD10, 
CD13, CD29, CD44, CD49d, CD59, CD73, CD90, CD105, CD106, CD166 and STRO-
1(Lindroos et al., 2008; Nam and Lee, 2009). Further, DPSC did not express CD14, CD 31, CD 
45 (Nam and Lee, 2009) (Summarized in Table 1). 
When cultured under osteogenic conditions DPSCs were capable of forming calcified 
deposits sparsely throughout the culture;  these results were unlike BMMSCs which formed 
sheets of calcium deposits (Gronthos et al., 2000). In vivo transplantation of DPSCs into 
immunocompromised mice resulted in the production of a dentin-pulp-like complex with a 
collagen matrix containing blood vessels and lined with odontoblasts (Gronthos et al., 2000) 
suggesting that DPSCs are multipotent. Further studies also found DPSCs to be multipotent, 
capable of differentiating into myoblasts, osteoblasts, odontoblast-like cells, chondrocytes, 
adipocytes and neural cells (Gronthos et al., 2002; Liu et al., 2006; Pierdomenico et al., 2005; 
Zhang et al., 2006). 
 
Letter 
name 
BMMSCs DPSCs SHEDs hNDPs PDLSCs SCAPs DFPCs 
CD9 + +   +  + 
CD 10  +  - +  + 
CD 13 + + + + + + + 
CD 14 - - -  - -  
CD 18      -  
CD 19  -      
CD 24  -   - +  
CD 29  + +  + + + 
CD 34 - - - - - - - 
CD 44 + + + + + + + 
CD 45 - - - - - - - 
CD 53       + 
CD 59  +   +  + 
CD73 + + + + + + + 
CD 90 + + + + + + + 
CD 105 + + +  + + + 
CD 106 + + +  + + + 
CD 146 + + + + + + + 
CD 150      -  
CD 166  + + + +  + 
STRO-1 + + +  + + + 
 
Table 1. Cell surface markers expressed in dental stem cells compared to bone marrow 
mesenchymal stem cells as determined by flow cytometry. Table adapted from Karaöz et al. 
2011, Rodriguez-Lozano et al. 2011, Huang, G.T. et al. 2009, Nam and Lee 2009, Lindroos et 
al. 2008 and Shi et al. 2005. BMMSCs, bone marrow mesenchymal stem cells; DPSCs, dental 
pulp stem cells; SHEDs, stem cells from human exfoliated deciduous teeth; SCAPs, stem 
cells from apical papilla; DFPCs, dental follicle precursor cells; hNDPs, stem cells derived 
from human natal dental pulp; + = marker present; - = marker absent. 
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2.4.2.1.2 Stem Cells from Human Exfoliated Deciduous Teeth  
SHEDs are found in the pulp of the naturally exfoliated deciduous teeth or “baby teeth.”  
When the permanent tooth erupts from the gums the deciduous tooth in displaced. SHED 
cells were first isolated by Miura et al. (2003) from the remnant pulp in the crown of human 
deciduous incisors of children 7-8 years old.  
Similar to DPSCs, SHEDs met the criteria to be defined as a stem cell population as they 
were highly proliferative, capable of self-renewal and had the ability to differentiate into 
multiple cell types (Miura et al., 2003).  SHEDs also had a fibroblast-like morphology similar 
to DPSCs. However, SHEDs were capable of a greater number of population doublings and 
had a higher proliferation rate than both BMMSCs and DPSCs (Miura et al., 2003). SHEDs 
have also been isolated and identified as immature dental pulp stem cells (IDPSCs) (Kerkis 
et al., 2006) and found to express embryonic stem cell markers Oct-4 (POU transcription 
factor), Nanog, stage specific embryonic antigens (SSEA-3, SSEA-4), and tumorigenic 
recognition antigens (TRA-1-60, TRA-1-81). SHEDs have also been shown to express neural 
stem cell markers SRY (sex determining region  Y)-box 2 (Sox-2), nestin, and ATP-binding 
cassette, subfamily G, member 2 (ABCg2)(Morsczeck et al., 2010).  
SHEDs were further characterized using FACS as having the following cell surface markers: 
CD13, CD29, CD31, CD44, CD73, CD90, CD105, CD146, CD166, and STRO-1 and similar to 
BMMSCs and DPSCs, SHEDs did not express CD14, CD34 or CD45 (Kerkis et al., 2006; 
Morsczeck et al., 2010; Pivoriuunas et al., 2010; Shi et al., 2005; Wang et al., 2010) 
(Summarized in Table 1). 
A distinguishing feature of SHEDs not demonstrated for DPSCs is SHEDs formed sphere-
like clusters when cultured in neuronal differentiation media (Miura et al., 2003). While 
Miura et al. (2003) demonstrated that SHEDs could differentiate into neural cells, adipocytes 
and odontoblasts, Kerkis et al. (2006) showed that SHEDs also had chondrogenic and 
myogenic potential. SHEDs were shown to express chondrogenic markers Sox-9, type II 
collagen and type X collagen when cultured for 14 days with bone morphogenic protein 2 
(BMP2), a chondrogenic signaling protein in the TGFǃ family (Koyama et al., 2009). 
Interestingly, Koyama et al. (2009) did not find any expression of the chondrogenic markers 
in their untreated populations of SHED cultures.  
When SHED were transplanted into immunocompromised mice they exhibited an 
osteoinductive capacity in vivo but were not able to regenerate the dentin-pulp-like complex 
that DPSCs cells were able to form (Miura et al., 2003). Kerkis et al. (2006) also showed that 
when SHEDs were transplanted into immunocompromised mice via intraperitoneal 
injection they engrafted into the lungs, liver, spleen, brain and kidney and the tissue formed 
by the SHEDs was indistinguishable from the host tissue for liver, spleen, brain and kidney 
(Kerkis et al., 2006).  
2.4.2.1.3 Stem Cells Derived from Human Natal Dental Pulp 
Natal teeth are deciduous teeth that arise in newborns that are smaller than primary teeth 
and have little or no root development (Leung and Robson, 2006). Karaöz et al. (2010) 
isolated and characterized hNDPs from the remnant pulp of natal teeth. A small number of 
hNDPs adhered to plastic in culture and displayed a fibroblast-like spindle shaped 
morphology that eventually became flattened in later passages (Karaöz et al., 2010). Similar 
to DPSCs, hNDPs had a higher proliferation rate the BMMSCs, were clonogenic, and had 
the ability to differentiate into multiple cell types, satisfying the criteria to be classified as a 
stem cell population.  
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Using flow-cytometry Karaöz et al. (2010) showed that like BMMSCs, hNDPs expressed 
CD13, CD44, CD73, CD90, CD146, and CD166 but did not express CD14, CD31 or CD45 
(Summarized in Table 1). Stem cells derived from human natal dental pulp expressed many 
of the same cell surface markers seen in DPSCs and SHEDs (Table 1).   
Cultures of NDPs with chondrogenic, osteogenic, adipogenic, myogenic and neurogenic 
media expressed the appropriate differentiation markers associated with their culture 
media. Further, the multipotent nature of hNDPs was demonstrated by their differentiation  
in vitro into chondroblasts, osteoblasts, adipocytes, myoblasts and neuro-glial-like cells 
respectively (Karaöz et al., 2010). Interestingly, hNDPs expressed detectable levels of the 
embryonic stem cell markers Rex-1, Oct4 and Nanog as well as the transcription factors Sox-
2 and FoxD3 suggesting that these cells display some of the characteristics for pluripotency 
(Karaöz et al., 2010).  
2.4.2.2 Periodontal Ligament Stem Cells 
The periodontal ligament is the part of the tooth derived from the neural crest and made of 
soft connective tissue that resides between the cementum and the alveolar bone of the jaw 
(Figure 1). It is responsible for anchoring and supporting the tooth within the tooth socket. 
The periodontal ligament is composed of a heterogeneous population of cells containing 
fibroblasts, osteoblasts and cementoblasts (Bartold et al., 2000; Gay et al., 2007; Lekic et al., 
2001; Seo et al., 2004; Shimono et al., 2003). Early studies have suggested that the PDL tissue 
had regenerative or repair abilities when an injury was incurred by the periodontal tissue 
(Reviewed in Bartold et al. (2005) and Shimono et al. (2003)). 
Periodontal ligament stem cells were first isolated by Seo et al. (2004) from impacted third 
molar adult teeth. Immunohistochemical staining of PDLSCs stained positive for early 
mesenchymal stem cell markers STRO-1 and CD146 suggesting that these cells has similar 
stem cell characteristics to BMMSCs (Seo et al., 2004). PDLSCs demonstrated other 
characteristics of BMMSCs and DPSCs including fibroblastic-like cell morphology that 
adhered to plastic and formed clonogenic cell clusters with the ability to differentiate into 
multiple cell types (Seo et al., 2004). PDLSCs had a higher proliferation rate than BMMSCs, 
but similar rate to DPSCs after 24 hours in culture (Seo et al., 2004). 
Multipotent human PDLSCs cells have been characterized using FACS sorting and were 
shown to express the following cell surface markers: CD9, CD10, CD13, CD29, CD44, CD59, 
CD73, CD90, CD105, CD106, CD146, CD166 and STRO-1 (Feng et al., 2010; Lindroos et al., 
2008; Shi et al., 2005; Wada et al., 2009). Like BMMSCs, DPSCs and SHEDs, PDLSCs do not 
express CD14, CD31 or CD45 (Shi et al., 2005)(Summarized in Table 1). PDLSCs have also 
been shown to express the embryonic stem cell markers Oct4, Sox-2, Nanog and Klf-4 and 
neural crest markers Nestin, Slug, p75 and Sox-10 (Huang et al., 2009a). 
Like BMMSCs and DPSCs, PDLSC’s formed calcium deposits when cultured in osteogenic 
media, however, unlike BMMSCs and DPSCs these deposits were sparsely distributed 
though out the culture (Gay et al., 2007; Seo et al., 2004). Increased protein expression of 
osteoblastic/cementoblastic markers alkaline phosphatase, bone sialoprotein, matrix 
extracellular protein, osteocalcin and TGFǃ receptor 1 was observed after osteogenic 
induction (Seo et al., 2004). PDLSCs were also capable of differentiation into adipocytes as 
demonstrated by the formation of oil red O positive droplets and the upregulation of 
adipocyte specific transcripts after 21-25 days of culture in adipogenic inducing media (Gay 
et al., 2007; Seo et al., 2004). Gay et al. (2007) showed that PDLSCs could undergo 
chondrogenic differentiation in vitro after 21 days culture.  
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When transplanted into immunocompromised mice PDLSCs formed a cementum/PDL-like 
structure with attached collagen fibers (Seo et al., 2004). However, despite the expression of 
osteogenic / cementoblastic markers in vitro (Gay et al., 2007; Seo et al., 2004), PDLSCs were 
unable to form dentin or bone in vivo (Seo et al., 2004). By implanting PDLSCs into 
immunocompromised rats with periodontal defects, Seo et al. (2004) were able to show that 
PDLSCs were capable of periodontal tissue repair. 
2.4.2.3 Stem Cells from the Apical Papilla  
SCAPs were first isolated by Sonoyama et al. (2006) from impacted wisdom teeth of adults 
aged 18-20. The apical papilla is a part of the soft tissue found at the apices of the immature 
permanent tooth that eventually becomes the pulp tissue in the mature tooth (Huang et al., 
2009b; Sonoyama et al., 2006; Sonoyama et al., 2008). Histological characterization of the 
apical papilla by Sonoyama et al. (2008) showed that the apical papilla is separate from the 
pulp canal and apical cell rich zone of the immature tooth. 
SCAPs expressed the early mesenchymal stem cell markers STRO-1 and CD146 suggesting 
that these cells were a stem cell population. Further characterization of this cell population 
showed that SCAPs formed adherent fibroblastic cell cultures that were clonogenic and 
capable of over 70 population doublings with the ability to transform into odontoblastic/ 
osteoblastic, adipogenic, chondrogenic and neural cell types (Abe et al., 2007; Sonoyama et 
al., 2006; Sonoyama et al., 2008). Sonoyama et al. (2006) also showed that SCAPs had a 
greater proliferation rate and population doubling than DPSCs isolated from the same tooth. 
SCAPs were also distinct from DPSCs with respect to expression levels of survivin, 
telomerase and the cell surface marker CD24, all which are thought to be associated with 
cell proliferation (Sonoyama et al., 2006).  
Analysis of cell surface markers by flow cytometry showed that SCAPs expressed CD13, 
CD24, CD29, CD73, CD90, CD105, CD106, CD146, CD166 and STRO-1 but did not express 
CD14, CD18, CD34, CD45, or CD150 (Abe et al., 2007; Sonoyama et al., 2006) (Summarized 
in Table1). 
In vitro culture of SCAPs, DPSCs and BMMSCs showed that SCAPs and DPSCs had similar 
osteo/dentinogenic potential to BMMSCs, but had a weaker response to adipogenic 
differentiation than BMMSCs (Sonoyama et al., 2008). After neural induction, 
immunostaining showed that SCAPs expressed the following neuronal markers: ǃIII 
tubulin, glial fibrillary acid protein, glutamic acid decarboxylase, nestin, neuronal nuclear 
antigen, neuronal filament M, neuron-specific enolase and 2′, 3′-cyclic nucleotide 3′-
phosphodiesterase (Abe et al., 2007; Sonoyama et al., 2008). When transplanted into 
immunocompromised mice SCAPs underwent in vivo differentiation into odontoblasts 
which regenerated the dentin-pulp-like structure and connective tissue (Sonoyama et al., 
2006). 
2.4.2.4 Dental Follicle Progenitor Cells  
As described above, the dental follicle is the ectomesodermal tissue surrounding the 
developing tooth that leads to the formation of cementoblasts, periodontal ligament and 
osteoblasts. Morsczeck et al. (2005) isolated human DFPCs from the dental follicle area of 
impacted wisdom teeth and noted that a small number had stem cell characteristics. DFPCs 
formed clonogenic, fibroblastic-like colonies in culture that adhered to plastic (Morsczeck et 
al., 2005). Like SHEDs, DFPCs expressed neural stem cell associated markers Sox-2, nestin, 
and ABCg2 (Morsczeck et al., 2010).  
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Interestingly, multipotent DFPCs have been reported in mice and rats that are capable of 
undergoing osteogenic, adipogenic, chondrogenic and neurogenic differentiation (Luan et 
al., 2006; Yao et al., 2008). However, only osteogenic differentiation has been demonstrated 
consistently for human DFPCs in vitro (Honda et al.; Kémoun et al., 2007; Lindroos et al., 
2008; Morsczeck et al., 2005). For human DFPCs neural induction has also been 
demonstrated by Morsczeck et al. (2010) but conflicting results for adipogenic and 
chondrogenic differentiation have been observed (Honda et al.; Kémoun et al., 2007; 
Lindroos et al., 2008). 
Immunohistochemistry and FACS sorting have shown that DFPCs express the following cell 
surface markers: CD9, CD10, CD13, CD29, CD44, CD53, CD59, CD73, CD90, CD105, CD106, 
CD146, CD166 and STRO-1 but do not express CD34 or CD45 (Lindroos et al., 2008; 
Morsczeck et al., 2010; Yagyuu et al., 2010). 
When Morsczeck et al. (2005) transplanted human DFPCs into severe combined 
immunodeficiency (SCID) mice they saw an increase in bone sialoprotein, osteocalcin and 
collagen I expression in vivo but did not see any evidence of cementum or bone 
formation. However, transplantation of mouse DFPCs into SCID mice demonstrated that 
DFPCs were capable of regenerating the PDL in vivo (Yokoi et al., 2007). Recently, when 
cryopreserved DFPCs were transplanted into immunocompromised rats, a mineralized 
tissue structure was formed in vivo containing cementocyte/osteocyte cells, but the exact 
identity of the tissue type could not be determined as dentin, cementum or bone (Yagyuu 
et al., 2010). 
3. Tissue engineering 
3.1 Dental stem cells in tissue engineering and regenerative medicine  
When tissues become damaged or non-functional tissue engineering is used to replace, 
repair or restore damaged tissue in the body (Levenberg and Langer, 2004). Tissue 
engineering and regenerative medicine requires an abundant cell source capable of 
differentiation into the required tissue.  Therefore, stem cells with their ability to self-renew, 
proliferate and differentiate make an ideal cell source for this type of tissue repair and 
replacement (Barrilleaux et al., 2006).  
Whole tooth regeneration is the goal of many researchers and much of tissue engineering 
involving dental stem cells is used to reconstruct or repair damaged and diseased dental 
tissue (Dannan, 2009; Huang et al., 2009b; Shi et al., 2005; Sonoyama et al., 2006; Yen and 
Sharpe, 2008; Yokoi et al., 2007).  When a patient’s dental pulp cavity becomes infected or 
diseased, often the entire pulp is removed and replaced with a filling. Due to the ability of 
DPSCs to form the dentine-pulp-like complex in vivo, it has been suggested that this may 
soon be an option for regenerative therapy of teeth (Caton et al., 2010). SHEDs also have 
shown potential for regenerating the dental-pulp-like tissue in vivo when transplanted into 
immunocompromised mice (Cordeiro et al., 2008) and therefore may be useful for future 
regenerative endodontic procedures. Further, Seo et al. (2004) showed that PDLs 
participated in periodontal tissue repair and formed a PDL/cementum-like complex when 
transplanted into immunocompromised mice suggesting that we will soon be able to 
regenerate tissues surrounding the teeth. Unfortunately one of the challenges remaining for 
whole tooth regeneration is that we are currently unable to regenerate human enamel 
(Mitsiadis and Papagerakis, 2011).  
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Two significant advancements in the area of whole tooth engineering are the ability to 
generate dental tissue structures in vitro and the ability to deliver these dental stem cells in 
vivo (Cordeiro et al., 2008; Yen and Sharpe, 2008). An important development in tissue 
engineering is the use of hydroxyapatite/ tricalcium phosphate (HA/TCP) particles and 
other carrier particles that allow dental stem cells cultured  in vitro and delivered in vivo 
(Caton et al., 2010; Sharma et al., 2010). Also important to for dental tissue engineering is 
developing appropriate biodegradable scaffolds that can be seeded with stem cells for use in 
transplants and that provide the correct 3D space for differentiation (Caton et al., 2010; 
Dannan, 2009; Huang, 2009; Sharma et al., 2010; Yen and Sharpe, 2008). Scaffolds are made 
from both synthetic polymers like polylactic acid (PLA), polyglycolic acid (PGA), 
polylacticco-glycolic acid (PLGA), and polycaprolactone (PCL)) or natural polymers like 
collagen, fibrin, polysaccharides and alginates (Sharma et al., 2010).  PGA fibers have been 
shown to be useful for engineering dental pulp-like tissue (Bohl et al., 1998).  
Dental stem cells are also used to repair or supplement other types of tissues including 
bone, heart and neuronal tissue (d'Aquino et al., 2009; Gandia et al., 2008; Huang et al., 
2009b; Wang et al., 2010). The potential of stem cells to regenerate bone tissue was 
demonstrated in a study by d’Aquino et al. (2007). These researchers showed that in vivo 
transplantation of human DPSCs in woven bone chips or polymer scaffolds into 
immunocompromised rats resulted in adult bone formation complete with de novo 
synthesis of blood vessels (d'Aquino et al., 2007). Potential treatment with DPSCs has also 
been tested using cardiac tissue in rats that have been subjected to a myocardial infarction. 
After transplanting DPSCs into the site of infarction via injection, there was a decrease in the 
size of the infarct and increased vessel formation near the infarct (Gandia et al., 2008). 
Interestingly, SHED cells have been used by researchers to produce dopaminergic neuron 
cells (Wang et al., 2010) to alleviate the effects of Parkinson’s disease in rats.  Wang et al. 
(2010) used a two-step induction protocol to stimulate SHED cells to form neurospheres 
which were then treated with a neurogenic cocktail to stimulate their differentiation into 
dopaminergic neurons. The formation of neurons by SHED cells suggests that dental cells 
may become an invaluable resource for neurodegenerative disease therapies. Another 
suggested application of stem cell therapy for SHEDs is for the treatment of wound healing 
(Nishino et al., 2011). Using a mouse model, SHEDs were transplanted into an excisional 
wound and were found to accelerate healing after 5 days when compared to control 
(Nishino et al., 2011). The potential use of dental stem cells has become even more viable for 
tissue regeneration and other therapies with the recent advances in cryopreservation. These 
advances allow proliferation and long term storage of these cells for future cell therapy 
treatments while maintaining their differentiation potential (Ding et al., 2010; Papaccio et al., 
2006; Seo et al., 2005; Woods et al., 2009; Zhang et al., 2006).   
3.2 Dental stem cells and dynamic compression  
Our lab is exploring the area of cellular based tissue engineering and in particular the effects 
of dynamic cyclic compression on chondrogenesis in two types of human dental stem cells, 
PDLSCs and SHEDs.  
Earlier work in our lab on biomechanical force has shown that short intervals of cyclic 
compression cause rabbit BMMSCs to up-regulate TGFǃ (Huang et al., 2005). TGFǃ3 has 
been shown to induce chondrogenic differentiation of BMMSCs in vitro (Barry et al., 2001) 
and the extracellular signal-related kinase (ERK) 1/2 signal transduction pathway of 
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mitogen activated protein kinases (MAPKs) has been implicated in this process (Lee et al., 
2004). The application of dynamic mechanical compression has been shown to induce 
chondrogenic differentiation of stem cells via an autocrine signaling pathway (Huang et al., 
2005). Interestingly, just two hours of cyclic compression applied to BMMSCs stimulated 
TGFǃ gene expression and the expression of both of its receptors (Huang et al., 2005). This 
stimulation in turn resulted in an up-regulation of the early response genes c-Fos and c-Jun 
as well as chondrogenic specific genes Sox-9, aggrecan and collagen type II (Huang et al., 
2005). 
Our lab has developed a line of adult dental stem cells derived from the PDL that are 
multipotent and express some ESC markers (Huang et al., 2009a). Using in vitro cultures in 
chondrogenic media we were able to show that after two weeks in culture with TGFǃ3, 
PDLSCs increased expression of the chondrogenic markers collagen II and aggrecan (Huang 
et al., 2009a). Further, we see that PDLSCs express chondrogenic markers when subject to 
dynamic cyclic compression in a custom built bioreactor. After applying 15% strain at 1 
Hertz for four hours we see a two to three fold increase in PDLSCs chondrogenic gene 
expression of Sox-9 and aggrecan as well as a 50% increase in ERK1/2 activity (Fritz, 2009). 
These results suggest that human PDLSCs, like BMMSCs, subject to dynamic cyclic 
compression require the ERK1/2 signaling pathway for chondrogenic expression (Fritz, 
2009).  
Recently we examined the effects of shorter durations of dynamic cyclic compression on 
SHEDs. As in previous experiments (Fritz, 2009; Pelaez et al., 2009), fibrin gel constructs 
were cast into 1.5-mm deep and 8-mm diameter Teflon molds set on top of a clean 
microscope slide. We loaded 1 X 107 SHEDs into 85 µL fibrin gel mixture containing 5 U/mL 
thrombin in PBS and 40 mg/mL fibrinogen in high-glucose DMEM. The fibrin gel constructs 
were allowed to solidify for one hour before removing from the Teflon mold and then 
placed in fibrin gel media containing high-glucose DMEM, 1% penicillin/streptomycin and 
1× ITS supplement (BD Biosciences, San Jose, CA) and 0.0875 IU/mL aprotinin from bovine 
lung (Sigma-Aldrich, St. Louis, MO) for 24 hours in a water-jacketed incubator at 37°C and 
5% CO2. The compression chambers were loaded with the fibrin gel constructs and 650 µL of 
fibrin gel media. Fibrin gel constructs were then subjected them to 1Hertz dynamic cyclic 
compression with 15% strain in a custom built bioreactor placed in a water-jacketed 
incubator at 37°C and 5% CO2. Twelve samples for each treatment were subjected to 0 
minutes, 15 minutes, 30 minutes, 60 minutes and 240 minutes of compression. Fibrin gel 
constructs were removed from the bioreactor and flash frozen in liquid nitrogen.  
Messenger RNA expression was determined using methods similar to Fritz (2009) and 
Pelaez et al. (2009). Briefely, fibrin gel constructs were homogenized using a IKA Ultra 
Turrax® T8 Homogenizer in 1 mL TRIzol (Invitrogen, Carlsbad, CA) and RNA was 
extracted according to manufacturers recommended protocol. Purified RNA concentration 
was quantified on a NanoDrop ND-1000 spectrophotometer. Reverse transcription of 
mRNA was performed using MultiScribe™ Reverse Transcriptase (Applied Biosciences, 
Foster City, CA) according to the manufacturer’s suggested protocol. Quantitative real-time 
PCR was performed in a MxPro 3005P machine (Stratagene) using SYBR® Green PCR 
Master Mix (Applied Biosciences, Foster City, CA) according to manufacturer’s suggested 
protocols. All samples were run in triplicate.  GADPH was used as a reference gene. Fold 
changes of the chondrogenic genes (Sox-9, c-fos, and TGFǃ3) were calculated from the log-
transformed CT values and expressed relative to the No Compression treatment group using 
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a modification of the delta-delta CT method (Livak and Schmittgen, 2001; Vandesompele et 
al., 2002).  
Protein was extracted from the fibrin gel scaffolds and levels of p-ERK assessed using the 
methods described in Fritz (2009). Briefly, fibrin gel constructs were homogenized in 1 mL 
of RIPA cell lysis buffer 2 (Enzo Life Sciences Int’l, Inc., Plymouth Meeting, PA) plus 0.5 
μL/mL protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 1 mM 
phenymethanesulfonyl fluoride (Sigma-Aldrich, St. Louis, MO). The homogenate was kept 
on ice for 40 minutes and vortexed every 10 minutes. The homogenate centrifuged and the 
remaining supernatant was saved for protein analyses. The level of p-ERK 1/2 in each 
sample was determined using [pThr202/Tyr204]Erk1/2 EIA kit (Enzo Life Sciences Int’l, Inc., 
Plymouth Meeting, PA). Manufacturer suggested protocols were performed for the EIA 
assays and all samples were analyzed in duplicates.  
All data are reported as mean ± S.E.M. (N=number of samples). 0 minutes, 15 minutes, 30 
minutes, 60 minutes and 240 minutes of compression were compared level of p-ERK 1/2 
and for mRNA expression of Sox-9, c-fos, and TGFǃ3. Significant differences were 
determined by using a One-way ANOVA in Sigma Stat 3.00 (SPSS Inc.). 
The effects of dynamic compression on chondrogenesis and ERK 1/2 signal transduction 
was observed (Figure 2). As expected, we saw an increase in the levels of the early response 
gene c-fos after 60 minutes of dynamic compression (Figure 2). Surprisingly, we did not see 
any change in the other early response gene c-jun (Data not shown) as seen in BMMSCs 
described above. We also saw an increase in the gene expression of both TGFǃ3 and Sox-9 
after 30 minutes of dynamic compression which lasted for at least 60 minutes of 
compression (Figure 2). Unlike the PDLSCs response to dynamic compression, SHEDs did 
not express Sox-9 after four hours. Further, we noticed and increase in the phosphorylation 
of ERK 1/2 as early as 15 minutes which was sustained for at least 60 minutes, but was no 
longer elevated after 4 hours (Figure 2). 
SHEDs clearly have a different response to dynamic compression than PDLSCs. Like 
PDLSCs we see an early rise in the phosphorylation of ERK 1/2 suggesting that this signal 
transduction pathway is responding to compressive forces in SHEDS. The rise in TGFǃ3 
likely triggers the chondrogenic differentiation. Similar to PDLSCs, we see an increase in 
Sox-9, a transcription factor for chondrocyte differentiation, suggesting that SHEDs are 
indeed beginning to undergo chondrogenic differentiation. However, unlike PDLSCs, we 
did not see any aggrecan expression in our experiment which arises later in chondrogenic 
differentiation. Therefore we can suggest that SHEDs, like PDLSCs, respond to compressive 
force by undergoing chondrogenic differentiation and this is likely mediated though the 
ERK 1/2 signal transduction pathway. However, although chondrogenic differentiation is 
triggered within 30 minutes by dynamic compression, it is not completed during these short 
time intervals. This may be due to the decrease in TGFǃ3 gene expression after 4 hours, 
which may be required to maintain chondrogenic differentiation in the dynamically 
compressed constructs as there was no supplementation of TGFǃ3 in the media. 
Interestingly, the control samples did not show any gene expression for aggrecan but these 
samples were maintained in media without any supplemental TGFǃ3. Koyama et al. (2009) 
did not show any chondrogenic gene expression in control cultures of SHEDs, but felt it 
may be due to the fact that some of their cultures were infected. We would suggest 
repeating that experiment to determine if SHEDs cultures express any of the chondrogenic 
markers without TGFǃ3 supplementation. 
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Fig. 2. The effects of different durations of dynamic cyclic compression (15% strain) on 
relative messenger RNA expression of c-fos, TGFǃ3 and Sox-9 and on the phosphorylation 
level of ERK 1/2. All treatments N=6. Values are means ± S.E.M.; *P < 0.05, significantly 
different from No Compression treatment. 
4. Dental stem cells versus embryonic stem cells  
There are advantages and disadvantages for using dental stem cells compared to the using 
embryonic stem cells for tissue engineering and regenerative medicine. One advantage of 
using dental stem cells compared to ESCs is in the ease of obtaining these cells as they can 
be obtained from tissue during a standard tooth extraction or through loss of primary teeth 
(Huang et al., 2009b). ESCs are obtained from the inner cell mass of the embryoblast (Biswas 
and Hutchins, 2007) which requires access to the early embryo.  An advantage of using 
embryonic stem cells is their pluripotent potential and their ability to differentiate into all 
three germ layers (Alison et al., 2002; Mummery et al., 2011; Thomson et al., 1998). Studies 
on dental stem cells have only shown them to only be multipotent (Gronthos et al., 2000; 
Karaöz et al., 2010; Miura et al., 2003; Morsczeck et al., 2005; Seo et al., 2004; Sonoyama et al., 
2006). Interestingly, one PDL cell line has shown a broad differentiation potential and 
expresses some of the pluripotent markers expressed by ESCs (Huang et al., 2009a). A 
previous disadvantage of culturing ESCs is that they require a mouse embryonic feeder 
layer but recent studies have shown that ESCs can be cultured using human serum and 
human feeder cells and these cultures can be maintained for an extensive period of time 
(Ellerström et al., 2006).  Dental stem cells do not require a feeder layer but only have a 
limited number of passages (See above).   
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Many of the problems encountered with stem cells delivery and scaffold choice are the same 
for both dental stem cells and ESCs. The use of dental stem cells or ESCs for tissue 
engineering or regenerative repair often produce similar results and many of the same types 
of problems arise. Currently whole tooth regeneration is not possible using ESCs or dental 
stem cells. Similar to dental stem cells, human ESCs have been used to form osteoblasts both 
in vitro and in vivo and had the capacity to form mineralized tissue (Bielby et al., 2004).  
Like DPSCs, ESCs have been used to repair cardiac function in infarcted myocardium. 
Human ESCs were injected into an infarcted mouse myocardium and were shown to 
improve cardiac function after four weeks but this improvement was not maintained after 
three months (van Laake et al., 2008).  ESCs have also been used to explore neuronal 
regeneration for patients affected with Parkinson disease. Using the monkey as a primate 
model, ESCs have been used to generate dopaminergic neurons to aid in the relief of 
Parkinson disease (Takagi et al., 2005).  
5. Concluding remarks  
This review shows that dental stem cells are a viable alternative to embryonic stem cells for 
regenerative medicine. Dental stem cells are easily obtainable from the dental pulp of teeth 
and from other dental tissues which are often discarded as waste. Further,  dental stem cells, 
like BMMSCs, form  clonogenic, highly proliferative, multipotent cell populations in vitro 
and maintain their differentiation potential in vivo. Dental stem cells also show potential for 
cell therapy with respect to whole tooth regeneration. More work needs to be done to 
optimize the use of dental stem cells for use in cell therapies of other tissue types in the 
future including bone and cartilage formation. The potential of dental stem cells as an 
alternative choice to embryonic stem cells seems realistic for future stem cell therapies and 
regenerative medicine.  
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